• AI Pickup
  • menu
  • U.S. Stock Market Prediction
    • U.S. Stock Forecast Tomorrow
    World Stock Markets
  • ETF Market Prediction
    • ETF Forecast Tomorrow
  • Cryptocurrency Prediction
  • Forex Market Prediction
  • Sign In Sign Up
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
Go to >>
Interactive chart
Long term forecast
Analyst ratings
Financial Info
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
Go to >>
Interactive chart
Long term forecast
Analyst ratings
Financial Info
Quick Access Forecast in this page:
Long term
Analysts
    You are here:
  • Home
  • USA stock market prediction
  • BMRN forecast

BioMarin Pharmaceutical Inc (BMRN) stock prediction

Will BioMarin Pharmaceutical Inc stock go up? Is BioMarin Pharmaceutical Inc stock a good buy now?

From AI system, total return is 1657.46% from 1318 forecasts. Forecast for Mar. 2021 is $72.77 , for Feb. 2022 is $86.88 , for Feb. 2024 is $171.84 , for Feb. 2026 is $269.38 , and for Feb. 2031 is $241.55.

Since closing price on 2021-02-26 is $77.43 and forecast for Feb. 2022 is $86.88, BioMarin Pharmaceutical Inc stock is a good 1 year investment. Please, see more forecasts below.

Table of contents

  • Interactive chart
  • Long term forecast
  • Analyst ratings by institutions
  • Financial Info
  • Frequently Asked Questions (FAQ)
  • 14 Days Historical Data

Statistics

Statistics from all past short term forecast signals in AI Pickup
Total return : 1657.46 %
Number of direction forecasts : 1318

Click to see the forecast history of all tickers

Chart for BioMarin Pharmaceutical Inc (BMRN) stock

<BMRN Chart by Tradingview>

Long term forecast for BioMarin Pharmaceutical Inc stock

BMRN long term forecast chart
Date
Price
Mar. 2021
$72.7741786745076
Apr. 2021
$67.7511156597408
May. 2021
$62.9785255400144
Jun. 2021
$59.6653067888299
Jul. 2021
$58.5498416643653
Aug. 2021
$59.8594362948162
Sep. 2021
$62.9299028001148
Oct. 2021
$67.1589437973477
Nov. 2021
$71.9965473734371
Dec. 2021
$77.0920697889761
Jan. 2022
$82.1934814887015
Feb. 2022
$86.8836071716729
Mar. 2022
$90.4680221583248
Apr. 2022
$92.1968981594295
May. 2022
$91.7241650286185
Jun. 2022
$90.4603015091704
Jul. 2022
$90.0614013028575
Aug. 2022
$90.6125554093496
Sep. 2022
$91.7469896193772
Oct. 2022
$93.3164693969275
Nov. 2022
$95.3515592594398
Dec. 2022
$97.8139644015574
Jan. 2023
$100.793103627532
Feb. 2023
$104.314953403621
Mar. 2023
$108.419312182205
Apr. 2023
$113.150971294897
May. 2023
$118.505882461242
Jun. 2023
$124.324061493142
Jul. 2023
$130.597460023501
Aug. 2023
$137.183289417396
Sep. 2023
$143.648952353104
Oct. 2023
$149.78485392942
Nov. 2023
$155.511647849419
Dec. 2023
$161.031304752777
Jan. 2024
$166.46143682549
Feb. 2024
$171.837244829995
Mar. 2024
$177.033926063107
Apr. 2024
$181.582516150343
May. 2024
$186.023074981995
Jun. 2024
$190.364643717747
Date
Price
Jul. 2024
$194.785751525686
Aug. 2024
$199.070567224957
Sep. 2024
$203.00154393489
Oct. 2024
$206.746627461811
Nov. 2024
$210.527817794889
Dec. 2024
$214.582806829443
Jan. 2025
$218.97895024124
Feb. 2025
$223.737434031331
Mar. 2025
$228.844590433798
Apr. 2025
$234.175269749988
May. 2025
$239.376577589335
Jun. 2025
$244.368897769547
Jul. 2025
$249.058252351479
Aug. 2025
$253.424592708113
Sep. 2025
$257.601338596748
Oct. 2025
$261.232491945135
Nov. 2025
$264.166627786713
Dec. 2025
$266.491728750047
Jan. 2026
$268.190252286499
Feb. 2026
$269.376090019548
Mar. 2026
$270.363581287804
Apr. 2026
$271.151241721765
May. 2026
$272.061892771469
Jun. 2026
$274.233390407806
Jul. 2026
$274.819369364979
Aug. 2026
$273.41272684937
Sep. 2026
$271.067384483758
Oct. 2026
$268.3114308148
Nov. 2026
$265.3783166821
Dec. 2026
$262.555084447477
Jan. 2027
$259.851912644649
Feb. 2027
$257.415079140742
Mar. 2027
$255.172717318908
Apr. 2027
$253.039215686275
May. 2027
$251.640592621473
Jun. 2027
$250.371379588566
Jul. 2027
$249.003619842856
Aug. 2027
$248.399867006731
Sep. 2027
$249.617551212697
Oct. 2027
$252.752385377238
Date
Price
Nov. 2027
$255.943085812066
Dec. 2027
$258.520124762415
Jan. 2028
$259.615396678417
Feb. 2028
$260.422180418149
Mar. 2028
$261.011899215361
Apr. 2028
$261.527727255498
May. 2028
$262.004865300995
Jun. 2028
$262.392459238321
Jul. 2028
$262.795590861586
Aug. 2028
$263.504251994087
Sep. 2028
$264.582868127643
Oct. 2028
$266.007515852516
Nov. 2028
$267.714868495866
Dec. 2028
$270.401191740988
Jan. 2029
$273.885026235846
Feb. 2029
$277.940227323186
Mar. 2029
$282.071844523504
Apr. 2029
$285.804166328227
May. 2029
$288.761165315615
Jun. 2029
$290.528201179395
Jul. 2029
$290.934552149498
Aug. 2029
$290.205707447298
Sep. 2029
$288.522297491214
Oct. 2029
$285.692954280856
Nov. 2029
$281.988064395601
Dec. 2029
$278.031217245805
Jan. 2030
$273.980430711915
Feb. 2030
$270.510630255969
Mar. 2030
$267.717201076509
Apr. 2030
$265.225927839238
May. 2030
$262.888759144641
Jun. 2030
$260.46493797077
Jul. 2030
$257.622351100064
Aug. 2030
$254.55215448013
Sep. 2030
$251.508830731409
Oct. 2030
$248.306313173157
Nov. 2030
$245.01930221854
Dec. 2030
$241.746074694998
Jan. 2031
$240.224441736927
Feb. 2031
$241.554070536251

Analyst rating for BioMarin Pharmaceutical Inc stock

Date
Firm
Analysis
2020-11-06
SVB Leerink
Price target is $108.0000. Prior price target was $113.0000.
Analyst rating is Outperform.
2020-09-10
Truist Securities
Price target is $125.0000. Prior price target was $130.0000.
Analyst rating is Buy.
2020-08-21
Morgan Stanley
Price target is $85.0000. Prior price target was $125.0000.
Analyst rating is Equal-Weight.
2020-08-20
Canaccord Genuity
Price target is $95.0000. Prior price target was $119.0000.
Analyst rating is Buy.
2020-08-20
RBC Capital
Price target is $92.0000. Prior price target was $123.0000.
Analyst rating is Sector Perform. Prior analyst rating was Outperform
2020-08-20
William Blair
Analyst rating is Market Perform. Prior analyst rating was Outperform
2020-08-20
Citigroup
Price target is $86.0000. Prior price target was $148.0000.
Analyst rating is Neutral. Prior analyst rating was Buy
2020-08-19
SVB Leerink
Price target is $113.0000. Prior price target was $140.0000.
Analyst rating is Outperform.
2020-08-19
Stifel
Price target is $100.0000. Prior price target was $127.0000.
Analyst rating is Hold. Prior analyst rating was Buy
2020-08-06
BMO Capital
Price target is $108.0000. Prior price target was $94.0000.
Analyst rating is Market Perform.
2020-08-05
SVB Leerink
Price target is $140.0000. Prior price target was $130.0000.
Analyst rating is Outperform.
2020-07-08
Morgan Stanley
Price target is $125.0000. Analyst rating is Equal-Weight. Prior analyst rating was Overweight
2020-06-18
SunTrust Robinson Humphrey
Price target is $143.0000. Prior price target was $109.0000.
Analyst rating is Buy.
2020-06-18
Oppenheimer
Price target is $95.00. Prior price target was $88.0000.
Analyst rating is Perform.
2020-06-10
B of A Securities
Price target is $130.0000. Prior price target was $120.0000.
Analyst rating is Buy.
2020-04-30
SunTrust Robinson Humphrey
Price target is $109.0000. Prior price target was $110.0000.
Analyst rating is Buy.
2020-04-30
Credit Suisse
Price target is $128.0000. Prior price target was $131.0000.
Analyst rating is Outperform.
2020-03-03
Morgan Stanley
Price target is $125.0000. Prior price target was $120.0000.
Analyst rating is Overweight.
2020-03-02
Wedbush
Price target is $164.0000. Prior price target was $175.0000.
Analyst rating is Outperform.
2020-01-28
BMO Capital
Price target is $94.0000. Analyst rating is Market Perform.
2020-01-24
RBC Capital
Analyst rating is Sector Outperform. Prior analyst rating was Sector Perform
2019-11-27
Barclays
Price target is $98.0000. Analyst rating is Overweight. Prior analyst rating was Equal-Weight
2019-11-12
SunTrust Robinson Humphrey
Price target is $110.0000. Analyst rating is Buy.
2019-10-30
Citigroup
Price target is $95.0000. Prior price target was $120.0000.
Analyst rating is Buy.
2019-10-28
Canaccord Genuity
Price target is $108.0000. Prior price target was $117.0000.
Analyst rating is Buy.
2019-10-25
Wedbush
Price target is $152.0000. Prior price target was $128.0000.
Analyst rating is Outperform.
2019-10-24
Barclays
Price target is $86.0000. Prior price target was $95.0000.
Analyst rating is Equal-Weight.
2019-10-24
Nomura
Price target is $77.0000. Prior price target was $93.0000.
Analyst rating is Neutral.
2019-10-17
Bank of America
Price target is $90.0000. Analyst rating is Buy.

Financial Data for BioMarin Pharmaceutical Inc stock

Market Cap
14055868416
Held Percent By Insiders
0.611%
Held Percent By Institutions
100.247%
Sector
Healthcare
Website
http://www.biomarin.com
currency
USD

Forward PE
1548.6
Trailing PE
16.980263
Enterprise Value
1.47922944E10
Enterprise To Ebitda
1974.419
Enterprise To Revenue
7.951

Average 10 day Volume
1120871
Average Volume
1420414
Fifty Two Week High
$131.95
Fifty Two Week Low
$68.25

Frequently Asked Questions for BioMarin Pharmaceutical Inc stock

Is BioMarin Pharmaceutical Inc a good long term stock?

For 1 year investment, BioMarin Pharmaceutical Inc (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical Inc stock price forecast for Feb. 2022 is $86.8836071716729
For 5 year investment, BioMarin Pharmaceutical Inc (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical Inc stock price forecast for Feb. 2026 is $269.376090019548
For 10 year investment, BioMarin Pharmaceutical Inc (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical Inc stock price forecast for Feb. 2031 is $241.554070536251

Is BioMarin Pharmaceutical Inc stock overvalued?

BioMarin Pharmaceutical Inc (BMRN) stock is expected to go UP . Therefore, AI Pickup would say that BioMarin Pharmaceutical Inc (BMRN) stock is NOT overvalued.

Will BioMarin Pharmaceutical Inc stock price go up?

Yes. The BioMarin Pharmaceutical Inc stock price forecast for Feb. 2022 is $86.8836071716729

14 Days Historical Data for BioMarin Pharmaceutical Inc stock

Date
Close
Open
Low
High
2021-02-08
$86.29
$86.16
$85.15
$87.29
2021-02-09
$85.61
$86.78
$84.83
$86.82
2021-02-10
$85.45
$86.28
$84.34
$86.65
2021-02-11
$86.86
$85.93
$84.93
$86.87
2021-02-12
$87.04
$86.27
$86.21
$87.84
2021-02-16
$84.94
$87.41
$84.14
$87.44
2021-02-17
$85.8
$84.54
$84.24
$86.16
2021-02-18
$83.27
$85.49
$82.83
$85.49
2021-02-19
$81.76
$83.58
$81.46
$83.76
2021-02-22
$81.06
$81.2
$80.13
$82.33
2021-02-23
$82.15
$80.5
$79.12
$82.55
2021-02-24
$83.32
$82.3
$82.2
$84.52
2021-02-25
$81.76
$83.38
$81.35
$83.95
2021-02-26
$77.43
$80.31
$75.3
$80.46
    • About
    • Company
    • Contact
    • Terms of Use
    • Privacy Policy
    • COPYRIGHT © 2020 by AI Pickup. All rights reserved.